Consistent with our findings in clinical cancerous tissues, we found that both GRK5 mRNA and protein expressions are unanimously upregulated in all NSCLC cancerous cell lines, with relative higher expression levels in A549 and H1299 cells (Fig. 2a, b). The gene discussed is GRK5; the disease is non-small cell lung carcinoma.